Can deferoxamine be considered an ototoxic drug?
Scand Audiol Suppl
; 30: 237-8, 1988.
Article
en En
| MEDLINE
| ID: mdl-3227279
ABSTRACT
Some uncertainty about deferoxamine ototoxicity is to be found in the literature. Therefore, 100 patients affected by beta-thalassemia were checked audiologically. Twelve of them showed a sensorineural hearing impairment which in most cases was confined to 4 and 8 kHz. If these results are compared with a sample of "normal" population, no significant difference can be observed, therefore excluding that deferoxamine, at least at present dosages, may be considered as a certain cause of cochlear impairment.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Talasemia
/
Deferoxamina
/
Pérdida Auditiva Sensorineural
Límite:
Adolescent
/
Adult
/
Child
/
Humans
Idioma:
En
Revista:
Scand Audiol Suppl
Año:
1988
Tipo del documento:
Article
País de afiliación:
Italia